The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...

AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

FAH rebuts Senate hearing claims, clarifying taxpaying hospitals do not benefit from the 340B drug pricing program discounts.

Even as they sparred on broader healthcare policy and funding topics fueling the ongoing government shutdown, senators of the ...

For the 5,000 people in Illinois living with sickle cell disease, access to affordable medical care and life-saving ...

HIV remains a persistent public health challenge in the United States. While infection rates have steadily declined over the past decade, access to proven prevention strategies—especially pre-exposure ...

Six drugmakers who have violated the 340B statute should immediately begin offering drugs at discounted prices to hospitals participating in the federal drug-pricing program, according to a letter ...

Commercial: Is the 340B Drug Pricing Program the Next 'Too Big to Fail'? WASHINGTON, Aug. 19, 2025 /PRNewswire/ -- ADAP Advocacy today, as part of its 340B Project, aired its latest commercial calling ...

The 340B Drug Pricing Program was created in 1992 and allows hospitals and clinics that treat a large population of low-income and uninsured patients to buy outpatient prescription drugs at a discount ...

The Ashtabula Regional Medical Center lost access to the 340B Drug Pricing Program this year. The program allowed the hospital system to purchase discounted specified outpatient drugs, ARMC Vice ...